TP53 and acute myeloid leukemia: Consistently with our previously reported results(14, 16), acute erythroid leukemia blasts express the highest levels of CCRL2 and TP53-mutated MDS/AML blasts express relatively higher levels of CCRL2 compared to de novo AML (Fig. 3C).